iSpecimen
ISPC
11 hedge funds and large institutions have $653K invested in iSpecimen in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.
4% more capital inflows, than outflows
Capital inflows: $29.2K | Capital outflows: $28.2K
0.1% more ownership
Funds ownership: 5.33% → 5.43% (+0.1%)
15% less funds holding
Funds holding: 13 → 11 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Claro Advisors
Boston,
Massachusetts
|
+$26.8K |
| 2 |
Tower Research Capital (TRC)
New York
|
+$2.44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Virtu Financial
New York
|
-$18K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$9K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1.22K |
ISPC Hedge Fund Activity: Q4 2022 in Review
11 of the 6,243 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q4 2022, worth a combined $653K — down 16% from $781K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ISPC and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Claro Advisors, opening a new position worth an estimated $26.8K. The largest seller was Virtu Financial, exiting entirely with an estimated $18K sold.
- 11 institutional investors held iSpecimen (ISPC) as of Q4 2022, down from 13 in Q3 2022.
- Funds reported $653K of iSpecimen stock for Q4 2022, down 16% quarter-over-quarter.
- 1 fund opened new iSpecimen positions in Q4 2022 and 3 closed out, a net change of -2 holders.
- The largest iSpecimen buyer in Q4 2022 was Claro Advisors, an estimated $26.8K added.
- The largest iSpecimen seller in Q4 2022 was Virtu Financial, an estimated $18K sold.
Based on aggregated 13F filings for Q4 2022.